Early studies indicate that the specific carbohydrate diet (SCD) may improve clinical symptoms and inflammatory biomarkers, but there is not enough high-quality evidence to be sure. N-of-1 (or single-subject repeated cross-over) trials are an ideal method for addressing this important research question. By focusing on the effect of diet for a single individual, N-of-1 studies […]
There is a clear unmet need for ulcerative colitis (UC) patients – only a quarter of UC patients achieve remission with present therapies. Currently, there is no standardized way that studies are conducted for UC, and each study is doing things slightly different, which makes the results hard to compare and slows drug development. The […]
The aims of this grant project were to develop two basic ideas that were just past the proof-of-concept stage, into functional computer code to perform processing of the large raw datasets supplied by the GutTracker wireless patch system, intended to form the first steps in the future standard data analysis. The first step was a cleanup […]
Thetis is developing TP-317 as a safe, oral therapy for ulcerative colitis patients whose disease is incompletely controlled by first-line therapy that would be an alternative to aggressive immuno-suppressive therapies. TP-317 is a novel derivative of Resolvin-E1, a molecule that is produced naturally by the body to regulate inflammation and promote healing. By delivering Resolvin-E1 […]
Thetis is developing TP-317 as a safe, oral therapy for treatment of ulcerative colitis and Crohn’s Disease. TP-317 is a novel derivative of Resolvin-E1, a molecule that is produced naturally by the body to regulate inflammation and promote healing. By delivering Resolvin-E1 to the small intestine and colon, TP-317 activates natural pathways to resolve inflammation […]
The project will use mouse models of colitis to investigate the effects of TP-317 (Resolvin E1 magnesium lysinate) in blood, feces and intestinal tissue on key biomarkers that are involved in IBD pathophysiology and that Resolvin E1 has been shown to regulate in prior experiments. Key biomarkers of interest include (a) cytokines such as G-CSF, […]
The study was an early phase clinical trial of Fecal Microbiota Transplant (FMT), delivered via different routes (colonoscopy and enema or oral capsules) for mild to moerate ulcerative colitis. Additionally, they investigated if pre-treatment with antibiotics prior to FMT has an impact on the outcome. 30 subjects were enrolled in the clinical trial. 20 subjects […]
The rapid advancement in scientific innovations could easily seem like fiction to the casual observer. Each day seems to give new examples of a future in which we have the capabilities to radically transform human life in a laboratory. Embodying these concepts and pushing the boundaries of science are themes central to a growing field […]
Crohn’s disease is an inflammatory bowel disease associated with significant morbidity. While the etiology is incompletely understood, alterations in intestinal microbiome composition and immune regulation play prominent roles in disease pathogenesis. Dietary therapies, including exclusive enteral nutrition, have been demonstrated to have favorable effects on disease activity but are limited by poor tolerability, high cost […]
Supports OUSD, Education for Change and Aspire schools to implement equitable and restorative practices through individual coaching and mindfulness training for leaders and educators.
